Mesoblast MESO
NASDAQ MESO
$17.28 +0.14 (+0.82%)
As of: Sep 4, 2026 · 3:17 PM EDT

Mesoblast (MESO) Interest Expenses (2014 - 2023)

Mesoblast (MESO) posted Interest Expenses of $4.5 million for Q2 2023, down 71.59% sequentially from $15.7 million in Q1 2023, and down 79.39% YoY from $21.6 million in Q2 2022.

Analysis

Mesoblast (MESO) Interest Expenses (2014 - 2023) Analysis & Trends

Mesoblast has reported Interest Expenses for 10 years, with the latest figure at $4.5 million in Q2 2023.

  • Quarterly Interest Expenses fell 79.39% year-over-year to $4.5 million in Q2 2023, while the trailing twelve-month figure through Dec 2024 was $4.5 million (down 85.45% YoY) and the FY2025 annual result came in at $23.0 million, changed 0.18% from the prior year.
  • Interest Expenses declined to $4.5 million in Q2 2023 per MESO's latest filing, from $15.7 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $21.6 million in Q2 2022 and troughed at -$5.4 million in Q4 2021.
  • A 5-year average of $6.3 million and a median of $4.0 million in 2020 frame the typical range for Interest Expenses.
  • The sharpest annual moves came in 2019 and 2021: Interest Expenses jumped 843.26% in 2019, then tumbled 234.7% in 2021.
  • Over 5 years, Interest Expenses stood at $3.6 million in 2019, then grew by 10.88% to $4.0 million in 2020, then sank by 234.7% to -$5.4 million in 2021, then surged by 298.61% to $10.7 million in 2022, then tumbled by 58.33% to $4.5 million in 2023.
  • According to Business Quant data, Interest Expenses over the past three periods registered $4.5 million, $15.7 million, and $10.7 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -1.00 Mn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn -
5 Revolution Medicines 44.02 Bn 44.02 Bn - 23.78 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 93.62 Mn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 20.27 Mn
10 Mesoblast 2.23 Bn 2.13 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -3.77 Mn
Mar 31, 2023 -4.98 Mn
Dec 31, 2022 -6.19 Mn
Sep 30, 2022 -4.50 Mn
Jun 30, 2022 -3.96 Mn
Mar 31, 2022 -3.91 Mn
Dec 31, 2021 -5.38 Mn
Sep 30, 2021 -3.66 Mn
Jun 30, 2021 -8.75 Mn
Mar 31, 2021 -3.23 Mn
Dec 31, 2020 -1.06 Mn
Sep 30, 2020 -2.90 Mn
Mar 31, 2020 -9.81 Mn
Dec 31, 2019 -6.40 Mn
Sep 30, 2019 -3.46 Mn
Jun 30, 2019 -3.42 Mn
Mar 31, 2019 -2.77 Mn
Dec 31, 2018 -2.49 Mn
Sep 30, 2018 -2.65 Mn
Jun 30, 2018 -1.41 Mn